DK0547952T3 - Anvendelse af modafinil til fremstilling af et antiisskæmisk lægemiddel - Google Patents

Anvendelse af modafinil til fremstilling af et antiisskæmisk lægemiddel

Info

Publication number
DK0547952T3
DK0547952T3 DK92403381.4T DK92403381T DK0547952T3 DK 0547952 T3 DK0547952 T3 DK 0547952T3 DK 92403381 T DK92403381 T DK 92403381T DK 0547952 T3 DK0547952 T3 DK 0547952T3
Authority
DK
Denmark
Prior art keywords
modafinil
manufacture
ischemic drug
ischemic
drug
Prior art date
Application number
DK92403381.4T
Other languages
English (en)
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Application granted granted Critical
Publication of DK0547952T3 publication Critical patent/DK0547952T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/065—Diphenyl-substituted acyclic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK92403381.4T 1991-12-13 1992-12-11 Anvendelse af modafinil til fremstilling af et antiisskæmisk lægemiddel DK0547952T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9115534A FR2684875B1 (fr) 1991-12-13 1991-12-13 Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.

Publications (1)

Publication Number Publication Date
DK0547952T3 true DK0547952T3 (da) 1996-01-22

Family

ID=9420051

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92403381.4T DK0547952T3 (da) 1991-12-13 1992-12-11 Anvendelse af modafinil til fremstilling af et antiisskæmisk lægemiddel

Country Status (12)

Country Link
US (1) US5391576A (da)
EP (1) EP0547952B1 (da)
JP (1) JPH0825873B2 (da)
KR (1) KR100252390B1 (da)
AT (1) ATE127342T1 (da)
AU (1) AU656642B2 (da)
DE (1) DE69204639T2 (da)
DK (1) DK0547952T3 (da)
FR (1) FR2684875B1 (da)
HU (2) HU216193B (da)
TW (1) TW244335B (da)
UA (1) UA27231C2 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697162B1 (fr) * 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
FR2706767B1 (da) * 1993-06-22 1995-09-08 Lafon Labor
FR2708201B1 (fr) * 1993-06-30 1995-10-20 Lafon Labor Utilisation de dérivés d'acétamide pour la fabrication de médicaments.
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
DE19943983A1 (de) * 1999-09-14 2001-03-15 Joseph Clasen Verwendung von Modafinil zur Herstellung eines plastizitätsfördernden Arzneimittels
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6492396B2 (en) * 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
CN100584322C (zh) * 2000-10-11 2010-01-27 赛福伦公司 包含莫达非尼化合物的组合物
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US7141555B2 (en) * 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
KR100911779B1 (ko) * 2001-05-25 2009-08-12 세파론, 인코포레이티드 모다피닐을 포함하는 고형 제약 제제
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
CA2511992A1 (en) * 2003-02-24 2004-09-10 Mallinckrodt Inc. Process for preparing benzhydrylthioacetamide
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US20060024370A1 (en) 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
KR101414831B1 (ko) * 2011-10-25 2014-07-04 이화여자대학교 산학협력단 모다피닐 또는 이의 유도체를 포함하는 ＫＣａ3.1 채널 매개 질환 치료용 조성물
WO2013062316A2 (ko) * 2011-10-25 2013-05-02 이화여자대학교 산학협력단 모다피닐 또는 이의 유도체를 포함하는 혈관질환 또는 ＫＣａ3.1 채널 매개 질환 치료용 조성물
KR101345860B1 (ko) * 2011-10-25 2013-12-30 이화여자대학교 산학협력단 모다피닐 또는 이의 유도체를 포함하는 혈관질환 치료용 조성물
ES2871381T3 (es) 2013-08-30 2021-10-28 Green Cross Wellbeing Corp Composición para prevenir y tratar la fatiga relacionada con el cáncer, que contiene polvo de ginseng procesado o extracto de ginseng procesado que tiene un componente de ginsenósido mejorado

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.

Also Published As

Publication number Publication date
UA27231C2 (uk) 2000-08-15
HU216193B (hu) 1999-05-28
US5391576A (en) 1995-02-21
DE69204639D1 (de) 1995-10-12
FR2684875B1 (fr) 1995-05-24
AU3008092A (en) 1993-06-17
KR100252390B1 (ko) 2000-05-01
ATE127342T1 (de) 1995-09-15
TW244335B (da) 1995-04-01
AU656642B2 (en) 1995-02-09
HU9203921D0 (en) 1993-03-29
KR930012022A (ko) 1993-07-20
HUT67784A (en) 1995-04-28
JPH0825873B2 (ja) 1996-03-13
EP0547952A1 (fr) 1993-06-23
DE69204639T2 (de) 1996-04-04
FR2684875A1 (fr) 1993-06-18
EP0547952B1 (fr) 1995-09-06
JPH0665070A (ja) 1994-03-08

Similar Documents

Publication Publication Date Title
DK0547952T3 (da) Anvendelse af modafinil til fremstilling af et antiisskæmisk lægemiddel
DK0751709T3 (da) Anvendelse af Bcl-2 til fremstilling af lægemidler til terapeutisk behandling og forebyggelse af sygdomme
DE69204283D1 (de) Gelstift antiperspiranten enthaltend 2-oxazolidinon-derivate und herstellungsverfahren.
NO306235B1 (no) Anvendelse av et legemiddel for behandling av artritt
DE69217134D1 (de) Katheterführungsdraht und Katheter
DE69210290D1 (de) Behandlungsvorrichtung
DK0731698T3 (da) Modafinil med defineret partikelstørrelse
NO933601D0 (no) Forbedret ligningsbasert treklebemiddel
DE69219726D1 (de) Intravenöse dosierungen überwachende vorrichtung
DE69421296D1 (de) Schmelzbehandlung
NO923859D0 (no) Medikament
DE69212427D1 (de) Integrierter elektro-optischer Modulator und dessen Herstellungsverfahren
DE69215954D1 (de) Angioplastie-Katheter und dessen Herstellungsverfahren
DE69215414D1 (de) Therapeutische Vorrichtung
DE69225733D1 (de) Formverfahren und -vorrichtung
DE3880480D1 (de) Hemolyse-inhibitor und plastifizierungsmittel.
NO911429L (no) Stoffbehandling.
DK0606333T3 (da) Afsvovlingsbehandling
NO922998D0 (no) Perforert drivkrutt, anordning for dets fremstilling og anvendelse av anordningen
NO179504C (no) Legemiddel i form av en tablett inneholdende diritromycin
NO911430D0 (no) Stoffbehandlingsmetode.
DE3852003D1 (de) Klöppel und Spannungsvorrichtung.
NO923455D0 (no) Indolsulfonamidsubstituert dihydropyridin, fremgangsmaate for fremstilling og anvendelse i legemidler
ATE114464T1 (de) Verwendung von zofenopril zur herstellung von medikamenten gegen rheumatoide arthritis.
FI945035A (fi) Pintasterilisointi laserkäsittelyn avulla